An unusual case of glipizide-induced proximal myopathy
- 1*,
- 2,
- 1,
- 3
- 1Nalmuri Block Primary Health Centre, South 24 Parganas, India.
- 2Department of Pharmacology, Swamy Vivekanandha College of Pharmacy, Namakkal, Tamil Nadu, India.
- 3Department of Clinical and Experimental Pharmacology, Calcutta School of Tropical Medicine, Kolkata, West Bengal, India.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Saibal Das
Nalmuri Block Primary Health Centre, South 24 Parganas, India.
Copyright: © 2016 The Author(s). This is an open access article.
Published: Jan 1, 2016, Received: Apr 3, 2015, Accepted: Aug 2, 2015
Abstract
This case report outlines a very rare case of glipizide‑induced severe proximal myopathy in a 61‑year‑old diabetic man. After taking 10 mg glipizide for 5 months, diabetes was well controlled but the patient presented with progressive proximal muscle weakness in all the four limbs. Clinical examination and relevant investigations suggested it to be a case of proximal myopathy and might be drug induced. De‑challenge was done and was treated resulting in reversal of the diseased state. After 3 more months, controlled re‑challenge was done and there was recurrence of proximal muscle weakness. There were no evidences of any other possible metabolic, infective, organic or other pathologic causes giving rise to that condition and Naranjo adverse drug reaction probability scale suggested that it was “probable” that glipizide was responsible for the development of myopathy in this patient.
Keywords
Subject
Readers Also Viewed
Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models
Annisa Fatharani, Ali Alsayegh
Jan 1, 2026
Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review
Mohammad Akbar Hossain
Jan 1, 2026
Knowledge, Attitude, and Practice on Digital Eye Strain Among Healthcare Students at a Private University in Northern Peninsular Malaysia
Lim Chin Hung, Subramani Parasuraman, Sam Aaseer Thamby
Jan 1, 2026